Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Mentice

DB:MN2
Snowflake Description

Exceptional growth potential with flawless balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MN2
DB
SEK1B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Mentice AB (publ) provides endovascular simulation solutions to the hospitals and training centers, and medical device manufacturers worldwide. The last earnings update was 33 days ago. More info.


Add to Portfolio Compare Print
  • Mentice has significant price volatility in the past 3 months.
MN2 Share Price and Events
7 Day Returns
-4.5%
DB:MN2
4.1%
DE Healthcare Services
7.3%
DE Market
1 Year Returns
-
DB:MN2
0.9%
DE Healthcare Services
-17.7%
DE Market
MN2 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Mentice (MN2) -4.5% -37.1% -48.1% - - -
DE Healthcare Services 4.1% -8.3% -18.1% 0.9% 24.9% 85.3%
DE Market 7.3% -17.9% -25.8% -17.7% -25.6% -29%
1 Year Return vs Industry and Market
  • No trading data on MN2.
  • No trading data on MN2.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Mentice undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Mentice to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Mentice.

DB:MN2 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Dividend Discount Model
Dividend Per Share Company Filings (2019-12-31) in SEK SEK 0.19880666666667
Payout Ratio Company Filings (2019-12-31) 475.5%
Discount Rate (Cost of Equity) See below 5%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:MN2
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.97
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.973 (1 + (1- 22%) (1.54%))
0.989
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.99
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (0.989 * 5.44%)
4.99%

Discounted Cash Flow Calculation for DB:MN2 using Dividend Discount Model Model

The calculations below outline how an intrinsic value for Mentice is arrived at by discounting future dividends to their present value. This approach is used for finance firms where free cash flow is difficult to estimate (e.g. Banks/ Insurance firms).

If the firm does not pay the majority of its earnings out as a dividend this method will often arrive at a value significantly lower than the share price.

See our documentation to learn about this calculation.

DB:MN2 Gordon Growth Model
Calculation Result
Value per share = Expected dividends per share / (Discount Rate - Perpetual growth rate)
= SEK0.2 / (4.99% - -0.39%)
SEK0.03
DB:MN2 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:MN2 represents 0.0875x of OM:MNTC
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.0875x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (SEK) x Listing Adjustment Factor
= SEK 3.69 x 0.0875
€0.32
Value per share (EUR) From above. €0.32
Current discount Discount to share price of €3.64
= -1 x (€3.64 - €0.32) / €0.32
-1026.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Mentice is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Mentice's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Mentice's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:MN2 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in SEK SEK-1.05
OM:MNTC Share Price ** OM (2020-03-30) in SEK SEK41.6
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.1x
Germany Market PE Ratio Median Figure of 400 Publicly-Listed Companies 16.36x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Mentice.

DB:MN2 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OM:MNTC Share Price ÷ EPS (both in SEK)

= 41.6 ÷ -1.05

-39.49x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Mentice is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • Mentice is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Mentice's expected growth come at a high price?
Raw Data
DB:MN2 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -39.49x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
88.1%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.29x
Germany Market PEG Ratio Median Figure of 254 Publicly-Listed Companies 1.2x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Mentice, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Mentice's assets?
Raw Data
DB:MN2 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in SEK SEK5.20
OM:MNTC Share Price * OM (2020-03-30) in SEK SEK41.6
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.88x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.43x
DB:MN2 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OM:MNTC Share Price ÷ Book Value per Share (both in SEK)

= 41.6 ÷ 5.20

8x

* Primary Listing of Mentice.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Mentice is overvalued based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess Mentice's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Mentice has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Mentice expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
88.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Mentice expected to grow at an attractive rate?
  • Mentice's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • Mentice's earnings growth is expected to exceed the Germany market average.
  • Mentice's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:MN2 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:MN2 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 88.1%
DB:MN2 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 29.2%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 28.6%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.3%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:MN2 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in SEK Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:MN2 Future Estimates Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 363 54 1
2021-12-31 269 36 31 1
2020-12-31 196 17 7 1
2020-03-31
DB:MN2 Past Financials Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income *
2019-12-31 149 -38 -21
2019-09-30 154 -8 -1
2019-06-30 161 11 8
2019-03-31 156 9 14
2018-12-31 157 16 20
2017-12-31 109 16 6

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Mentice's earnings are expected to grow significantly at over 20% yearly.
  • Mentice's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:MN2 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Mentice Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:MN2 Future Estimates Data
Date (Data in SEK Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 2.26 2.26 2.26 1.00
2021-12-31 1.30 1.30 1.30 1.00
2020-12-31 0.28 0.28 0.28 1.00
2020-03-31
DB:MN2 Past Financials Data
Date (Data in SEK Millions) EPS *
2019-12-31 -1.05
2019-09-30 -0.02
2019-06-30 0.33
2019-03-31 0.64
2018-12-31 0.90
2017-12-31 0.29

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Mentice is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Mentice's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Mentice has a total score of 6/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Mentice performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Mentice's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Mentice does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Mentice's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Mentice's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Mentice's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Mentice Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:MN2 Past Revenue, Cash Flow and Net Income Data
Date (Data in SEK Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 149.37 -20.60 143.10
2019-09-30 154.32 -0.58 135.11
2019-06-30 160.63 8.07 128.48
2019-03-31 156.24 14.40 121.97
2018-12-31 157.05 20.15 115.55
2017-12-31 108.97 6.18 83.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Mentice has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Mentice has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Mentice improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Mentice's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Mentice has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Mentice's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Mentice's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Mentice is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Mentice's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Mentice's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Mentice has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Mentice Company Filings, last reported 3 months ago.

DB:MN2 Past Debt and Equity Data
Date (Data in SEK Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 125.51 0.00 48.04
2019-09-30 119.05 0.00 63.11
2019-06-30 127.72 0.00 84.89
2019-03-31 58.85 0.00 11.39
2018-12-31 66.74 0.00 17.82
2017-12-31 48.64 0.00 14.71
  • Mentice has no debt.
  • Mentice has not taken on any debt in the past 5 years.
  • Mentice has no debt, it does not need to be covered by operating cash flow.
  • Mentice has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess Mentice's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Mentice has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Mentice's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Mentice dividends. Estimated to be 0.48% next year.
If you bought €2,000 of Mentice shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Mentice's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Mentice's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:MN2 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.9%
Germany Minimum Threshold Dividend Yield 10th Percentile 1%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:MN2 Future Dividends Estimate Data
Date (Data in SEK) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 0.38 1.00
2021-12-31 0.22 1.00
2020-12-31 0.00 1.00
2020-03-31
DB:MN2 Past Annualized Dividends Data
Date (Data in SEK) Dividend per share (annual) Avg. Yield (%)
2020-02-27 0.000 0.000
2019-11-25 0.000 0.000
2019-08-29 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Mentice has not reported any payouts.
  • Unable to verify if Mentice's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Mentice's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Mentice has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Mentice's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Mentice's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Mentice afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Mentice has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Mentice's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Göran Malmberg
AGE 60
TENURE AS CEO 12 years
CEO Bio

Mr. Goran Malmberg serves as Group Chief Executive Officer and President at Mentice AB. Mr. Malmberg had been the Chief Executive Officer and President of Mentice AB since March 2008. Mr. Malmberg has extensive sales and marketing experience from executive positions within the software industry and has held sales management and senior executive roles with international focus during the last 15 years. Prior to joining Mentice, Mr. Malmberg served as President and Chief Executive Officer of Opticore from 2005 to 2007. He served as a Vice President of Auto-trol Technology Denver, Co., from 1989 to 1992 and also served as Department Manager of Cap Gemini from 1985 to 1989. He served as Vice President and held various Director positions at PTC from 1992 to 2002. He held various consulting and Board positions in software and consulting related businesses from 2002 to 2005. He served as a Director of Mentice AB. He completed a Master of Science in Mechanical Engineering from Linköping Technical University, Sweden from 1980 to1984.

CEO Compensation
  • Insufficient data for Göran to compare compensation growth.
  • Insufficient data for Göran to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Mentice management team in years:

3.7
Average Tenure
53
Average Age
  • The tenure for the Mentice management team is about average.
Management Team

Göran Malmberg

TITLE
Group CEO & President
AGE
60
TENURE
12 yrs

Elisabet Lund

TITLE
Chief Financial Officer
AGE
51
TENURE
8.2 yrs

Benjamin Speich

TITLE
Vice President of Global Operations
AGE
37
TENURE
1.2 yrs

Henrik Storm

TITLE
Chief Technical Officer
AGE
47
TENURE
6.2 yrs

Matar Dakhil

TITLE
Executive Vice President of Sales
AGE
55
TENURE
1.2 yrs

Thanos Karras

TITLE
Vice President of Global Marketing
AGE
56
TENURE
1 yrs
Board of Directors Tenure

Average tenure and age of the Mentice board of directors in years:

2.9
Average Tenure
60
Average Age
  • The average tenure for the Mentice board of directors is less than 3 years, this suggests a new board.
Board of Directors

Lonnie Howell

TITLE
Chairman
AGE
66

Magnus Hardmeier

TITLE
Director
AGE
60
TENURE
14.2 yrs

Bengt Sjöholm

TITLE
Director
AGE
66
TENURE
6.2 yrs

Johann Koss

TITLE
Director
AGE
51
TENURE
5.2 yrs

David Ballard

TITLE
Director
AGE
63
TENURE
0.6 yrs

Denis Gestin

TITLE
Independent Director
AGE
55
TENURE
0.6 yrs

Gösta Johannesson

TITLE
Independent Director
AGE
60
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Mentice individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
12. Mar 20 Buy Matar Dakhil Individual 12. Mar 20 12. Mar 20 15,609 €4.69 €73,201
X
Management checks
We assess Mentice's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Mentice has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Mentice AB (publ) provides endovascular simulation solutions to the hospitals and training centers, and medical device manufacturers worldwide. The company operates through three segments: Medical Device Industry, Teaching Entities, and Healthcare systems. It offers flight simulations to physicians and clinical teams. The company’s products are used to educate, train, and enhance the practitioner’s skills in various types of interventions and new clinical instruments. It also offers support, clinical support and education, onsite event support, short-term rental, hosting, and product and usage training services. The company was founded in 1999 and is headquartered in Gothenburg, Sweden.

Details
Name: Mentice AB (publ)
MN2
Exchange: DB
Founded: 1999
SEK90,841,087
24,146,552
Website: http://www.mentice.com
Address: Mentice AB (publ)
Odinsgatan 10,
Gothenburg,
Västra Götaland County, 411 03,
Sweden
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OM MNTC Ordinary Shares OMX Nordic Exchange Stockholm SE SEK 18. Jun 2019
DB MN2 Ordinary Shares Deutsche Boerse AG DE EUR 18. Jun 2019
Number of employees
Current staff
Staff numbers
101
Mentice employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 00:28
End of day share price update: 2020/03/30 00:00
Last estimates confirmation: 2020/03/03
Last earnings filing: 2020/02/27
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.